126
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Formulation Compatibility of Myristyl Nicotinate with Drugs Used to Treat Dermatological Conditions Involving an Impaired Skin Barrier

, , &
Pages 1176-1182 | Published online: 25 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Bashar Altaani, Razan Haddad, Aliaa Al-Tarakji & Nasr Alrabadi. (2022) Hydrolysis kinetics of the prodrug myristyl nicotinate. Pharmaceutical Development and Technology 27:10, pages 1083-1092.
Read now
Fatima Z. Abu Zanat, Amjad M. Qandil & Bassam M. Tashtoush. (2011) A promising codrug of nicotinic acid and ibuprofen for managing dyslipidemia. I: Synthesis and in vitro evaluation. Drug Development and Industrial Pharmacy 37:9, pages 1090-1099.
Read now

Articles from other publishers (2)

Mitsuko Masutani & Hiroaki Fujimori. (2013) Poly(ADP-ribosyl)ation in carcinogenesis. Molecular Aspects of Medicine 34:6, pages 1202-1216.
Crossref
Bassam M. Tashtoush, Amjad M. Qandil, Elaine L. Jacobson & Myron K. Jacobson. (2008) Analysis and Stability Study of Octyl Nicotinate in Aqueous Solutions and Skin Homogenate by LC. Chromatographia 68:1-2, pages 135-138.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.